High-risk non-muscle-invasive bladder cancer
Clinical trials for High-risk non-muscle-invasive bladder cancer explained in plain language.
Never miss a new study
Get alerted when new High-risk non-muscle-invasive bladder cancer trials appear
Sign up with your email to follow new studies for High-risk non-muscle-invasive bladder cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough bladder cancer: immune drug plus chemo combo enters trial
Disease control Not yet recruitingThis study tests whether adding chemotherapy drugs (gemcitabine and mitomycin C) directly into the bladder alongside an immune-boosting drug (toripalimab) works better than toripalimab alone for people with a high-risk bladder cancer that did not respond to standard BCG therapy. …
Matched conditions: HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Bladder cancer patients may get new hope from virus treatment
Disease control Not yet recruitingThis phase 2 trial tests a virus-based drug given directly into the bladder for people with high-risk non-muscle invasive bladder cancer. The virus is designed to attack cancer cells and trigger the immune system. About 18 participants will receive increasing doses to find the sa…
Matched conditions: HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Bladder cancer trial pits radiotherapy against standard immunotherapy
Disease control Not yet recruitingThis phase 3 trial compares radiotherapy with a radiosensitiser to the standard BCG immunotherapy for high-risk non-muscle invasive bladder cancer. About 328 patients will be randomly assigned to one of the two treatments after tumor removal. The goal is to see which approach bet…
Matched conditions: HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Phase 3 • Sponsor: The Christie NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC